17 May 2024 Blog How to be clear about royalty payments in a pharmaceutical licensing transaction A recent Court of Appeal case looks at how to draft royalty clauses in a pharmaceutical patent licence, where claim scope and validity may be uncertain, and the product at an early stage of development. Share this article Bookmark this page 4 min read
16 May 2024 Insight Greenwashing: Where are we now? Organisations are feeling the pressure more than ever to offer sustainable and environmentally conscious products and services to consumers. However, with the push to appear more eco-friendly comes the risk of over-exaggerating or misleading others with statements about green credentials. Bookmark this page 4 min read
10 May 2024 Blog MHRA issues its first medicinal product approval through the International Recognition Procedure The MHRA has promised a pro-innovation agenda for life sciences. The first approval of a medicinal product through the International Recognition Procedure is a welcome step for industry and patients alike. Share this article Bookmark this page 2 min read
23 April 2024 Insight CMA publishes final principles on AI Foundation Models On 16 April 2024, the Competition and Markets Authority published a technical update report relating to the CMA’s review of Artificial Intelligence Foundation Models. Bookmark this page 3 min read
Environmental, Social and Governance (ESG) We help you keep pace with the changes, challenges and opportunities in this rapidly evolving landscape. Read more about ESG